Are you looking to reduce your risk of getting breast cancer or preventing a recurrence? If so, taking a good look at how and what you eat can be the key. Here are some questions to consider in putting together your own game plan.
Is your body mass index, or BMI, between 21 and 25?
If you answered yes, then you are off to a great start! Probably the most important goal in the prevention of breast cancer or recurrence is to achieve or maintain a healthy weight, which is defined as a BMI between 21 and 24.9. If your BMI is greater than 25, follow a healthy diet that focuses on regular meals consisting of half your plate containing fruits and vegetables, one-fourth containing lean protein and another one-fourth containing whole grains. Adding in daily exercise, even just 30 minutes of walking, can further help you reach your weight goal and prevent breast cancer.
Last Friday evening, the University of Michigan Health System and The Forbes Company, owners of the Somerset Collection, partnered in a “Maize and Blue Go Pink” benefit to support breast cancer research at the University of Michigan Comprehensive Cancer Center. With approximately 300 people in attendance, Nathan and Catherine Forbes, Dr. Ora Hirsch Pescovitz, University of Michigan Executive Vice President for Medical Affairs and U-M Health System CEO, and the Somerset Collection turned a tent in the middle of downtown Detroit into “The Pink House.”
The evening, emceed by former NFL and Wolverine standout Steven Hutchinson and his wife, Landyn, featured a strolling dinner provided by favorite restaurants from Detroit and Ann Arbor.
Special touches included maize and blue M&Ms, block “M” Legos and centerpieces constructed of products and memorabilia from both Detroit and U-M. But it was the incredibly stylish fashion show and amazing performances from The Vandellas and The Contours that crowned a truly spectacular evening!
While we are still tallying official numbers and will not have a final tally until the end of the month when the special silent auction currently happening at Somerset Collection closes, we are thrilled to share that our gross revenue to date for breast cancer research has surpassed $118,000, and continues to grow. If you are unable to make it over to Somerset Collection, you can still help out by making a donation.
Experience the evening in pictures.
The University of Michigan Comprehensive Cancer Center’s 1,000 doctors, nurses, care givers and researchers are united by one thought: to deliver the highest quality, compassionate care while working to conquer cancer through innovation and collaboration. The center is among the top-ranked national cancer programs, and #1 in Michigan for cancer patient care. Seventeen multidisciplinary clinics offer one-stop access to teams of specialists for personalized treatment plans, part of the ideal patient care experience. Patients also benefit through access to promising new cancer therapies.
Cancer is caused at the molecular level by a large variety of genetic alterations that modify cell behaviors, making it a highly diverse disease. While the majority of the genetic alterations that give rise to or contribute to the development of cancer are due to chance, approximately 5% to 10% of these genetic alterations are inherited. Increasingly, genetic testing plays an important role in both detection and treatment.
Breast cancer is the most common cancer in women that carries a significant chance for loss of life. With the discovery and Continue reading →
Cancer doesn’t affect all ethnic groups the same. Certain types of cancer are more common in some groups than others. Liver and stomach cancer occur at higher rates within the Asian American community. Studies have also shown that Asian Americans have lower rates of cancer screening compared to other groups in the United States. Within the Asian American community, Korean Americans are the least likely to undergo screenings for colon, cervical and breast cancer. The following are some facts about Asian Americans and cancer:Continue reading →
Arul Chinnaiyan, M.D., Ph.D., and Scott Tomlins, M.D., Ph.D.
The University of Michigan Health System announced yesterday that it has begun offering a new urine test that could help detect prostate cancer and save a man from an unnecessary prostate biopsy. More than 1 million men will have a prostate biopsy this year, but only about one-fifth of those biopsies will result in a cancer diagnosis.The new early detection test for prostate cancer, available through MLabs, is called Mi-Prostate Score.
The test is based on a discovery from the lab of Dr. Arul Chinnaiyan of a gene fusion (TMPRSS2:ERG) that is involved in half of prostate cancer. By looking for the gene fusion along with PSA and other urinary marker for prostate cancer, the Mi-Prostate Score improves Continue reading →
Is ovarian cancer really a silent disease? It’s sometimes called that because early stages of ovarian cancer rarely cause symptoms. If symptoms are present, they tend to be vague and not specific to the ovaries. Unfortunately, this lack of symptoms can often delay detection and diagnosis until the cancer is at an advanced stage when the chance for cure is smaller.
The National Cancer Institute notes, “ovarian cancer has the highest mortality of all cancers of the female reproductive system, yet comprises only 3% of all cancers in women.” Part of this is due to the fact there is no widely-available screening method for the early detection of ovarian cancer yet. Therefore knowing the risk factors and symptoms of the disease are key.
Ovarian Cancer Symptoms
Women should note the following symptoms and if they are new or persist daily for more than two weeks, should Continue reading →